Ocera Therapeutics Inc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ocera Therapeutics Inc with three other
companies in this sector in the United States:
Eyegate Pharmaceuticals Inc
sales of $669,259.00
Dyadic International, Inc.
of which 100%
was Diagnostic Substance).
Sales increased substantially in 2016:
During the year ended December of 2016, sales at
Ocera Therapeutics Inc were $609,000.00 .
increase of 357.9%
versus 2015, when the company's sales were $133,000.00 .